PT  - JOURNAL ARTICLE
AU  - KAMRAN HARATI
AU  - PAWEL SLODNIK
AU  - ANSGAR MICHAEL CHROMIK
AU  - OLE GOERTZ
AU  - TOBIAS HIRSCH
AU  - NIKOLAI KAPALSCHINSKI
AU  - LUDGER KLEIN-HITPASS
AU  - JONAS KOLBENSCHLAG
AU  - WALDEMAR UHL
AU  - MARCUS LEHNHARDT
AU  - ADRIEN DAIGELER
TI  - Resveratrol Induces Apoptosis and Alters Gene Expression in Human Fibrosarcoma Cells
DP  - 2015 Feb 01
TA  - Anticancer Research
PG  - 767--774
VI  - 35
IP  - 2
4099  - http://ar.iiarjournals.org/content/35/2/767.short
4100  - http://ar.iiarjournals.org/content/35/2/767.full
SO  - Anticancer Res2015 Feb 01; 35
AB  - Background/Aim: Metastatic fibrosarcomas still represent a therapeutic dilemma. Commonly used chemotherapeutic agents such as doxorubicin have been proven effective in fewer than 30% of all cases disseminated of fibrosarcoma. Elderly patients with cardiac disease are not suitable for systemic chemotherapy with doxorubicin. We therefore tested the apoptotic effects of the natural and well-tolerated compound resveratrol on human fibrosarcoma cells (HT1080). Materials and Methods: Vital, apoptotic and necrotic cells were quantified using flow cytometric analysis. Gene expression was analyzed by RNA microarrays. Results: Application of resveratrol induced apoptotic cell death and significantly reduced proliferation of HT1080 cells. Correspondingly, expression of apoptosis-associated genes was altered in microarray analysis. Conclusion: This in vitro study demonstrates the anticancer activity of resveratrol against human fibrosarcoma cells. These results provide experimental support for in vivo trials assessing the effect of the natural polyphenol resveratrol.